Drug Pipeline

Lenacapavir Tablet Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
5
Active Studies
2
Recruiting
1
Phase 3
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-05-30 NCT07473778
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention		 Trial sites expanded: 10 -> 17 locations
Active Studies by Phase
Phase 3
1
Phase 2
3
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07047716 Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP) HIV Pre-exposure Prophylaxis Recruiting
Phase 2
NCT06101342 Study of Lenacapavir and Emtricitabine/Tenofovir Disoproxil Fumarate (F/TDF) for… Pre-Exposure Prophylaxis of HIV Infection Active, Not Recruiting
NCT05729568 A Study of Teropavimab and Zinlirvimab in Combination With Capsid Inhibitor Lenacapavir… HIV-1 Infection Active, Not Recruiting
NCT06513312 Study of Lenacapavir Taken Twice a Year for HIV Pre-Exposure Prophylaxis (PrEP) Pre-Exposure Prophylaxis of HIV Infection Active, Not Recruiting
Not specified
NCT07473778 Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention HIV Infections Recruiting
Sponsors Running Lenacapavir Tablet Trials
Gilead Sciences (5)
Get alerts when Lenacapavir Tablet trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free